All PlansCoverageMedium impact
Genetic Testing (CPB 0140, reviewed 2026-06-01)
Aetna·Genetics, Oncology, OB-GYN +4 more·Genetic Testing
Effective date
Jun 1, 2026
We identified it
Aug 17, 2026
Summary
Aetna has updated its Genetic Testing policy (CPB 0140, effective June 1, 2026) establishing comprehensive medical necessity criteria for genetic testing across multiple conditions. Key changes include: multi-gene panel tests are now limited to specific inherited cancer syndromes with documented clinical presentation or family history (all other multi-gene panels are experimental); carrier screening expanded to include pan-ethnic panels (≥15 genes) for recessive conditions with ≥1/200 carrier frequency; and disease-specific testing criteria now require documented clinical features, failed conventional diagnostics, and genetic counseling prior to testing authorization.
Action Required
By June 1, 2026: (1) Billing team must update prior authorization protocols to require documentation of: clinical features or pre-symptomatic risk status, direct impact on treatment, failed conventional diagnostic studies, genetic counseling completion, and pedigree analysis BEFORE submitting genetic testing claims. (2) Implement system rules to deny claims for multi-gene panel tests unless member meets specific inherited cancer syndrome criteria per NCCN guidelines or has documented personal/family history of related cancers. (3) Flag all repeat carrier screening requests as non-covered (experimental). (4) For inherited cancer testing: implement 'once in lifetime' benefit tracking in billing system to prevent duplicate authorizations. (5) Providers must document on encounter forms whether NCCN testing criteria are met for cancer syndromes and confirm genetic counseling was performed. (6) Update denial reason codes to distinguish between 'insufficient medical necessity documentation' and 'multi-gene panel not covered for this indication.' Claims submitted without required documentation or for non-qualifying multi-gene panels will be denied.